Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Classificação em ações
#3625
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Preço da ação
$3.71
Valor de mercado
$4.69B
Variação (1 dia)
2.44%
Variação (1 ano)
-51.92%
País
CN
Negociar Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categoria
Healthcare
Rácio P/S de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Rácio P/S em October 2026 TTM: 15.67
De acordo com os relatórios financeiros mais recentes e o preço das ações da Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., o rácio P/S atual (TTM) é 15.67. No final de 2023, o rácio P/S era 17.18.
Histórico do rácio P/S da Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. de 2013 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 15.67 | -62.38% |
| 2024 | 41.67 | 142.53% |
| 2023 | 17.18 | 69.95% |
| 2022 | 10.11 | -48.04% |
| 2021 | 19.46 | -35.13% |
| 2020 | 29.99 | 775.33% |
| 2019 | 3.43 | -14.52% |
| 2018 | 4.01 | 1.37% |
| 2017 | 3.95 | -11.91% |
| 2016 | 4.49 | -19.44% |
| 2015 | 5.57 | -11.75% |
| 2014 | 6.31 | -13.45% |
| 2013 | 7.30 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| 10.02 | -36.06% |
US
|
|
| 40.55 | 158.70% |
US
|
|
| 3.96 | -74.73% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -35.27% |
NL
|
